Performance Evaluation of the VIDAS TB-IGRA on Active tuberculosis study. - NA

BIOMERIEUX SA0 个研究点目标入组 40 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•A person who meets at least one of the criteria below, classifying him/her as suspected of having M. tuberculosis disease (active TB):
•- AFB-positive smear microscopy
•- Positive nucleic acid amplification test (NAAT) for M. tuberculosis
•- Clinical signs/symptoms
•- Clinical imagery such as chest X-ray or CT scan compatible with active TB

•1. A person who has been on an anti-TB treatment for more than 15 days for the ongoing infection (for MDR-TB, this refers to the second-line treatment)
•2. Pregnant women (self-reported)
•3. A person who has received an anti-TNF treatment within the previous 3 months
•4. A person who has had a TST in the previous 12 weeks
•5. A person who has been diagnosed with a NTM infection
•6. A person with positive HIV status, confirmed by a laboratory test or via a rapid test performed at time of inclusion or within one month prior to inclusion into this study

发起方